Pay in 4 interest-free payments of $6.23 Learn more
Ships within 48 hours · Estimated delivery Oct 6 - Oct 11
DSIP Dosage Guide DSIP is not currently approved for human use and there are no official dosing guidelines in place for this compound
By: Staff July 14, 2026 July 13, 2026 15:00 Nearly two-fifths (37 per cent) of Canadian employers cover glucagon-like peptide-1 therapies for both diabetes and weight loss, up from 31 per cent in 2025 and just 17 per cent in 2024, according to a new survey by the International Foundation of Employee Benefit Plans
When clinicians talk about peptides that support mood, they are usually referring to compounds that influence brain signaling, stress hormones, or neuroplasticity, the brain's ability to adapt and form new connections
GLP-1
Providing a Medical History Share details about any existing conditions, such as heart disease, kidney problems, or thyroid disorders, as these may affect your eligibility
US$ 26.53
US$ 20.52
US$ 24.38
US$ 25.37
)
